Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection
- PMID: 32807426
- PMCID: PMC7274589
- DOI: 10.1016/j.jstrokecerebrovasdis.2020.105011
Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection
Abstract
The current COVID-19 pandemic has recently brought to attention the myriad of neuro- logic sequelae associated with Coronavirus infection including the predilection for stroke, particularly in young patients. Reversible cerebral vasoconstriction syndrome (RCVS) is a well-described clinical syndrome leading to vasoconstriction in the intracra- nial vessels, and has been associated with convexity subarachnoid hemorrhage and oc- casionally cervical artery dissection. It is usually reported in the context of a trigger such as medications, recreational drugs, or the postpartum state; however, it has not been described in COVID-19 infection. We report a case of both cervical vertebral ar- tery dissection as well as convexity subarachnoid hemorrhage due to RCVS, in a pa- tient with COVID-19 infection and no other triggers.
Keywords: COVID-19; Convexity subarachnoid hemorrhage; Coronavirus,; Reversible cerebral vasoconstriction syndrome; Vertebral artery dissection.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
References
-
- Topcuoglu M.A., Singhal A.B. Hemorrhagic reversible cerebral vasoconstriction syndrome: features and mechanisms. Stroke. 2016;47:1742–1747. - PubMed
-
- Mawet J., Boukobza M., Franc J., Sarov M., Arnold M., Bousser M.-G. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology. 2013;81:821–824. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
